May 08 2026SCIENCE
Testing a New Brain Cancer Drug: What Research Shows So Far
Doctors often face tough choices when treating aggressive brain tumors. A recent trial looked at how well a drug called regorafenib works in newly diagnosed and recurring glioblastoma cases. Instead of traditional methods, researchers used a flexible approach where patient data influenced treatment
reading time less than a minute
